1429347-59-0Relevant articles and documents
NOVEL COMPOUNDS
-
Paragraph 0294-0295, (2015/03/28)
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.
NOVEL COMPOUNDS
-
Page/Page column 43; 46, (2013/11/18)
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.